Drug Resistance, Multiple
"Drug Resistance, Multiple" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Simultaneous resistance to several structurally and functionally distinct drugs.
| Descriptor ID |
D018432
|
| MeSH Number(s) |
G07.690.773.984.300
|
| Concept/Terms |
Drug Resistance, Multiple- Drug Resistance, Multiple
- Multiple Drug Resistance
- Resistance, Multiple Drug
- Multidrug Resistance
- Multi-Drug Resistance
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Multiple".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Multiple".
This graph shows the total number of publications written about "Drug Resistance, Multiple" by people in this website by year, and whether "Drug Resistance, Multiple" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 0 | 3 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 2 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 3 | 3 | 6 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 2 | 3 |
| 2019 | 3 | 0 | 3 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Resistance, Multiple" by people in Profiles.
-
Potential P-glycoprotein (P-gp) inhibitors from SuperDRUG2 database toward reversing multidrug resistance in cancer treatment: Database mining, molecular dynamics, and binding energy estimations. J Mol Graph Model. 2025 06; 137:108997.
-
Determining a urinary-specific antibiogram and risk factors of trimethoprim/sulfamethoxazole, ciprofloxacin and multidrug resistance among Enterobacterales in primary care. J Antimicrob Chemother. 2024 03 01; 79(3):559-563.
-
SuperNatural inhibitors to reverse multidrug resistance emerged by ABCB1 transporter: Database mining, lipid-mediated molecular dynamics, and pharmacokinetics study. PLoS One. 2023; 18(7):e0288919.
-
Feature-Based Molecular Networking for the Exploration of the Metabolome Diversity of Common Egyptian Centaurea Species in Relation to Their Cytotoxic Activity. Molecules. 2023 Jan 09; 28(2).
-
Prediction of 28-day mortality in acute decompensation of cirrhosis through the presence of multidrug-resistant infections at admission. J Gastroenterol Hepatol. 2020 Mar; 35(3):461-466.
-
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors. Genes Dev. 2019 07 01; 33(13-14):871-885.
-
Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES). BMC Nephrol. 2019 04 25; 20(1):138.
-
Cytotoxicity of 40 Egyptian plant extracts targeting mechanisms of drug-resistant cancer cells. Phytomedicine. 2019 Jun; 59:152771.
-
5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells. Toxicol Appl Pharmacol. 2019 01 01; 362:136-149.
-
Risk factors for infection after pediatric lung transplantation. Transpl Infect Dis. 2018 Dec; 20(6):e13000.